SCHEMBL29716634

SCHEMBL29716634

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NTSR2 O95665 6/20 0.75
▸ NTSR1 P30989 6/20 0.75
▸ SORT1 Q99523 4/20 0.75
▸ TACR1 P25103 1/20 0.66
▸ F2 P00734 1/20 0.59
▸ GNRHR P30968 1/20 0.56
▸ ABCC2 Q92887 1/20 0.56
▸ C5AR1 P21730 1/20 0.56
▸ CXCR4 P61073 1/20 0.56
▸ PTGS1 P23219 1/20 0.55
▸ APLNR P35414 1/20 0.54
▸ OPRM1 P35372 1/20 0.54
▸ OPRD1 P41143 1/20 0.54
▸ OPRK1 P41145 1/20 0.54
▸ DPP3 Q9NY33 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535981 0.91 TACR1 (0.78) NTSR2NTSR1SORT1TACR1F2
SCHEMBL29543021 0.91 TACR1 (0.78) NTSR2NTSR1SORT1TACR1F2
SCHEMBL29350118 0.91 TACR1 (0.78) NTSR2NTSR1SORT1TACR1F2
SCHEMBL34470399 0.90 NTSR2 (0.66) NTSR2NTSR1SORT1TACR1C5AR1
SCHEMBL29497199 0.88 NTSR1 (0.79) NTSR2NTSR1SORT1TACR1GNRHR
SCHEMBL31507728 0.88 NTSR2 (0.68) NTSR2NTSR1SORT1TACR1C5AR1
SCHEMBL31477723 0.88 TACR1 (0.74) NTSR2NTSR1SORT1TACR1F2
SCHEMBL29405987 0.88 TACR1 (0.74) NTSR2NTSR1SORT1TACR1F2
SCHEMBL30518127 0.87 NTSR2 (0.69) NTSR2NTSR1SORT1TACR1OPRM1
SCHEMBL30974182 0.86 NTSR2 (0.70) NTSR2NTSR1SORT1TACR1C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090251-A1 METHODS FOR IMPROVING TREATMENT OUTCOMES IN PATIENTS UNDERGOING ULTRAFILTRATION PROLETARIAT THERAPEUTICS, INC. (US) 2026-04-30 — — WO claimed
WO-2026090251-A1 METHODS FOR IMPROVING TREATMENT OUTCOMES IN PATIENTS UNDERGOING ULTRAFILTRATION PROLETARIAT THERAPEUTICS, INC. (US) 2026-04-30 — — WO disclosed
EP-4529468-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING Danmarks Tekniske Universitet (DK) 2025-04-02 — — EP disclosed
EP-4529477-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2025-04-02 — — EP disclosed
CN-118420708-A Urechis unicinctus reconstruction peptide ACE (angiotensin converting enzyme) inhibitory peptide and application thereof in medicines for preventing or treating hypertension 北京石油化工学院 2024-08-02 — — CN disclosed
WO-2023227518-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
WO-2023227517-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
EP-4282448-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2023-11-29 — — EP disclosed
EP-4282435-A1 FORMULATIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS AND EXCIPIENTS IN ICELLS VIA HYDROPHOBIC ION PAIRING Danmarks Tekniske Universitet (DK) 2023-11-29 — — EP disclosed
JP-2022093127-A GENETICALLY MODIFIED RICE, AND RICE DERIVED FROM THE GENETICALLY MODIFIED RICE, FOOD COMPOSITION, PROPAGATION MATERIAL, SEED AND CELL 国立研究開発法人農業・食品産業技術総合研究機構 2022-06-23 — — JP disclosed
Send feedback